See more : Excelsior Medical Co., Ltd. (4104.TW) Income Statement Analysis – Financial Results
Complete financial analysis of LPI Capital Bhd (8621.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LPI Capital Bhd, a leading company in the Insurance – Property & Casualty industry within the Financial Services sector.
- Yamada Servicer Synthetic Office Co.,Ltd (4351.T) Income Statement Analysis – Financial Results
- The Goldman Sachs Group, Inc. (GS.SW) Income Statement Analysis – Financial Results
- Wanxiang Qianchao Co.,Ltd. (000559.SZ) Income Statement Analysis – Financial Results
- Baytex Energy Corp. (BTE.TO) Income Statement Analysis – Financial Results
- China Harzone Industry Corp., Ltd (300527.SZ) Income Statement Analysis – Financial Results
LPI Capital Bhd (8621.KL)
Industry: Insurance - Property & Casualty
Sector: Financial Services
Website: https://www.lpicapital.com
About LPI Capital Bhd
LPI Capital Bhd, an investment holding company, underwrites general insurance products for individuals and commercial entities in Malaysia, Singapore, and Cambodia. It offers insurance solutions in the areas of employee benefits, health, liability, motor, marine, pecuniary, personal accident, project, property, and trade credit insurance. The company also provides fire, workmen's compensation, aviation, bond, miscellaneous, and engineering insurance products and services. It serves customers through agents. The company was formerly known as London & Pacific Insurance Company Berhad and changed its name to LPI Capital Bhd in May 1999. The company was incorporated in 1962 and is headquartered in Kuala Lumpur, Malaysia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.23B | 1.19B | 1.23B | 1.22B |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.32B | 1.23B | 1.19B | 1.23B | 1.22B |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 51.55M | 46.70M | 50.08M | 52.48M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.32B | 51.55M | 46.70M | 50.08M | 52.48M |
| Other Expenses | 0.00 | -935.82M | -800.06M | -849.72M | 0.00 |
| Operating Expenses | 1.32B | -884.28M | -753.36M | -799.64M | 806.39M |
| Cost & Expenses | 34.28M | 884.28M | 749.99M | 792.67M | 806.39M |
| Interest Income | 0.00 | 324.00K | 105.45M | 90.47M | 0.00 |
| Interest Expense | 1.15M | 1.25M | 1.57M | 1.83M | 1.45M |
| Depreciation & Amortization | 12.51M | 13.82M | 13.27M | 12.75M | -414.39M |
| EBITDA | 407.44M | 355.52M | 447.21M | 439.35M | 331.00K |
| EBITDA Ratio | 30.84% | 29.00% | 37.67% | 35.83% | 0.03% |
| Operating Income | 1.29B | 341.70M | 433.94M | 426.60M | 414.39M |
| Operating Income Ratio | 97.41% | 27.87% | 36.55% | 34.79% | 33.90% |
| Total Other Income/Expenses | -892.13M | -865.87M | 3.38M | 6.97M | 330.00K |
| Income Before Tax | 394.93M | 341.70M | 437.32M | 433.57M | 414.72M |
| Income Before Tax Ratio | 29.89% | 27.87% | 36.83% | 35.36% | 33.92% |
| Income Tax Expense | 81.21M | 89.48M | 92.64M | 96.84M | 92.36M |
| Net Income | 313.73M | 252.22M | 344.68M | 336.73M | 322.36M |
| Net Income Ratio | 23.74% | 20.57% | 29.03% | 27.46% | 26.37% |
| EPS | 0.79 | 0.63 | 0.87 | 0.85 | 0.81 |
| EPS Diluted | 0.79 | 0.63 | 0.87 | 0.85 | 0.81 |
| Weighted Avg Shares Out | 398.38M | 398.38M | 398.38M | 398.38M | 398.38M |
| Weighted Avg Shares Out (Dil) | 398.38M | 398.38M | 398.38M | 398.38M | 398.38M |
Source: https://incomestatements.info
Category: Stock Reports